Navigation Links
New Class of Drugs Might Treat Many Conditions
Date:5/9/2008

-- an inner ear condition affecting hearing and balance -- brain hemorrhage, and small-cell lung cancer, have had promising results, Decaux's team noted.

Despite these promising results, one expert isn't ready to called vaptans a miracle cure yet.

"This is nice review of an emerging class of drugs," said Dr. Gary S. Francis, director of the coronary intensive care unit at the Cleveland Clinic. "But it is a little early to know if they will prove to be highly useful."

More information

For more on conivaptan, visit the U.S. Food and Drug Administration.



SOURCES: Gary S. Francis, M.D., director, coronary intensive care unit, Cleveland Clinic; May 10, 2008, The Lancet


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

1

GOOD

Page: 1 2

Related medicine news :

1. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
2. ADDA Kicks Off AD/HD Awareness Campaign with Four Regional Conferences Beginning Sept. 29 and Series of Fall Teleclasses
3. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
4. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
5. Theater Classes Help Docs Bedside Manners
6. Tarpinian: Misclassification is Theft
7. New class of RNA molecules may be important in human cancer
8. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
9. Consumer Group: Hillary Clintons Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Cant Afford $12k Policy
10. SATELLITE BROADCAST: Consumer Group Says Hillary Clintons Mandatory Health Insurance Plan is an Act of War on the Middle Class that Cant Afford $12k Policy
11. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Class of Drugs Might Treat Many Conditions
New Class of Drugs Might Treat Many Conditions
(Date:5/13/2008)...y 13 /PRNewswire-FirstCall/ -- Z Trim Holdings, In... filed financial statements,for the fiscal year en...alification received from its independent register...his announcement is being made to comply with,Sect...separate disclosure,of receipt of an audit opinion...
(Date:5/13/2008)...Year-Ahead Nursing Home Funding Harms Patients,Th...May 13 /PRNewswire-USNewswire/ -- Commenting on a,...,s proposed regulatory,changes that will cut Medic...lion in the year ahead -- the 4th highest level of...iation (THCA) today warned the Medicare funding,cu...
(Date:5/13/2008)... Highlights, - Third quarter fiscal 2008 ... in the same quarter last year. -...nts for Dietary Supplement Manufa...RNewswire-FirstCall/ -- Natural,Alternatives Inter...,formulator, manufacturer and marketer of customiz...
(Date:5/13/2008)...2008 Mothers, heres another reason to encourage y...oung women who exercise regularly between the ages...reast cancer before menopause compared to those wh... largest and most detailed analysis to date of the...r, the study of nearly 65,000 women found that tho...
Breaking Medicine News(10 mins):Health News:Z Trim Holdings, Inc. Audit Report Contains 'Going Concern' Qualification 2Health News:New Study: Texas Seniors 4th Hardest-Hit from Proposed Bush Administration Medicare Cuts 2Health News:New Study: Texas Seniors 4th Hardest-Hit from Proposed Bush Administration Medicare Cuts 3Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 2Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 3Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 4Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 5Health News:Girls, young women can cut risk of early breast cancer through regular exercise 2
...ers now say people who are considered obese are si...beat // according to a recent study . They say th...artbeats can lead to earlier death, even when peop...nging the heartbeat back to normal. Researchers sa...
...hritis of the knee is very common, affecting almos...thritis is an incurable illness //, so treatment i...ich is why acupuncture was studied. Acupuncture in...the knee is more effective than drug treatment alo...
...atients treated with ultrasound therapy in additio... // compared to patients only treated with medicat...d 126 patients who suffered acute ischemic stroke ... artery. All the patients were treated with tissue...
...arch shows inhaled insulin is effective and well t...treatment also provides glycemic control comparabl..., 335 participants randomly received either inhale... to three injections of regular insulin for six mo...
Other Medicine News:
(Date:5/12/2008)...neurological recovery in severely-injured, acute ...with Cethrin, HOPKINTON, Mass., May 12 /PRNewswir...daq: ALSE ) today announced 12-month interim data... proprietary recombinant,protein that is being inv...ensory function after spinal cord injury, or SCI. ...
(Date:5/12/2008).../PRNewswire-USNewswire/ -- GlaxoSmithKline (GSK),...up (BIG), a leading,academic breast cancer researc...sh Breast Cancer Cooperative Group (SOLTI), today ...at will examine the role of TYKERB(R) in the,treat...t Lapatinib and/or,Trastuzumab Treatment Optimizat...
(Date:5/9/2008)...RNewswire-USNewswire/ -- Many strong acting pain,m... include nausea and,vomiting with short-term use, ...mptoms can lead patients to discontinue treatment,...t for physicians. The novel investigational,medica..., provided pain,relief for patients with fewer gas...
(Date:5/9/2008)...hase III Study Shows Positive Results with X-ray ...J., May 9 /- Roche today announced on... showing that ACTEMRA(TM),(tocilizumab) can signif...o,joints in patients with rheumatoid arthritis (RA...eatment. The study also demonstrated that ACTEMRA,...
Breaking Medicine Technology:Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Walnuts Rank High on New Nutrition Scales 12319 1Walnuts Rank High on New Nutrition Scales 12319 2Walnuts Rank High on New Nutrition Scales 12319 3Groundbreaking Deloitte Survey Reveals Many U S Consumers Want Major Changes in Health Care Design Delivery 12317 1Groundbreaking Deloitte Survey Reveals Many U S Consumers Want Major Changes in Health Care Design Delivery 12317 2Groundbreaking Deloitte Survey Reveals Many U S Consumers Want Major Changes in Health Care Design Delivery 12317 3Groundbreaking Deloitte Survey Reveals Many U S Consumers Want Major Changes in Health Care Design Delivery 12317 4Achilles Tendon Surgery Advances Speed Recovery 12315 1Achilles Tendon Surgery Advances Speed Recovery 12315 2Varian Medical Systems Announces Symposia on RapidArc Technology for Faster More Precise Radiotherapy Treatments 12313 1Varian Medical Systems Announces Symposia on RapidArc Technology for Faster More Precise Radiotherapy Treatments 12313 2Varian Medical Systems Announces Symposia on RapidArc Technology for Faster More Precise Radiotherapy Treatments 12313 3
...Against Rheumatism,(EULAR) Congress Demonstrates t...h Rheumatoid Arthritis, LONDON, England; PHILADELP..., 2007 /PRNewswire-FirstCall/ -- GlaxoSmithKline,(...itive primary,efficacy data (evaluated at 24 Weeks...an Congress of Rheumatology (abstract,number: OPO2...
...amoxifen in,a Single Trial , LUTON, UK, Friday 15... single trial has demonstrated that survival in,ea... switching from,tamoxifen to anastrozole (Arimidex...NO 95) study, published online in The,Journal of C...en,who have been taking tamoxifen as part of their...
Other Medicine Technology:GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: